| Primary |
| Essential Thrombocythaemia |
58.6% |
| Product Used For Unknown Indication |
10.5% |
| Thrombocythaemia |
3.2% |
| Computerised Tomogram |
2.8% |
| Rash |
2.8% |
| Hypertension |
2.4% |
| Upper Respiratory Tract Infection |
2.4% |
| Hyperuricaemia |
2.0% |
| Diabetes Mellitus |
1.6% |
| Psoriatic Arthropathy |
1.6% |
| Aspiration Bone Marrow |
1.4% |
| Breast Cancer |
1.4% |
| Migraine |
1.4% |
| Thrombosis Prophylaxis |
1.4% |
| Anaemia |
1.2% |
| Arteriosclerosis Obliterans |
1.2% |
| Dry Eye |
1.2% |
| Thrombocytosis |
1.2% |
| Drug Use For Unknown Indication |
1.0% |
| Headache |
1.0% |
|
| Acute Myeloid Leukaemia |
15.2% |
| Myelodysplastic Syndrome |
12.5% |
| Renal Impairment |
9.8% |
| Cytogenetic Abnormality |
6.3% |
| Skin Ulcer |
5.4% |
| Death |
4.5% |
| Gastrointestinal Haemorrhage |
4.5% |
| Platelet Count Increased |
4.5% |
| Pneumonia |
4.5% |
| Palpitations |
3.6% |
| Transient Ischaemic Attack |
3.6% |
| Weight Decreased |
3.6% |
| Wrist Fracture |
3.6% |
| Cardiac Failure |
2.7% |
| Drug Exposure During Pregnancy |
2.7% |
| Essential Thrombocythaemia |
2.7% |
| Overdose |
2.7% |
| Pulmonary Embolism |
2.7% |
| Pulmonary Oedema |
2.7% |
| Renal Failure |
2.7% |
|
| Secondary |
| Essential Thrombocythaemia |
46.7% |
| Hypertension |
7.5% |
| Psoriatic Arthropathy |
4.7% |
| Diabetes Mellitus |
4.6% |
| Migraine |
4.2% |
| Upper Respiratory Tract Infection |
3.8% |
| Depression |
3.0% |
| Anaemia |
2.8% |
| Thrombosis Prophylaxis |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Computerised Tomogram |
2.2% |
| Rash |
2.2% |
| Ear Pain |
2.0% |
| Arteriosclerosis Obliterans |
1.9% |
| Dry Eye |
1.9% |
| Breast Cancer |
1.6% |
| Supraventricular Extrasystoles |
1.6% |
| Ventricular Extrasystoles |
1.6% |
| Pharyngitis |
1.6% |
| Prostatic Disorder |
1.4% |
|
| Cytogenetic Abnormality |
10.0% |
| Gastroenteritis |
9.4% |
| Overdose |
9.4% |
| Pericardial Effusion |
7.5% |
| Delirium |
5.6% |
| Drug Exposure During Pregnancy |
5.6% |
| Guillain-barre Syndrome |
5.6% |
| Altered State Of Consciousness |
5.0% |
| Cardio-respiratory Arrest |
5.0% |
| Ventricular Fibrillation |
5.0% |
| Abortion Spontaneous |
4.4% |
| Labour Complication |
4.4% |
| Drug Dependence |
3.8% |
| Maternal Exposure During Pregnancy |
3.8% |
| General Physical Health Deterioration |
3.1% |
| Cardiac Failure |
2.5% |
| Embolism |
2.5% |
| Epistaxis |
2.5% |
| Orthostatic Hypotension |
2.5% |
| Pulmonary Embolism |
2.5% |
|
| Concomitant |
| Osteoporosis |
23.7% |
| Systemic Lupus Erythematosus |
19.1% |
| Drug Use For Unknown Indication |
8.3% |
| Chronic Myeloid Leukaemia |
6.6% |
| Myelofibrosis |
5.8% |
| Thrombocytopenia |
5.4% |
| Platelet Count Increased |
4.1% |
| Myeloproliferative Disorder |
3.7% |
| Anaemia |
2.9% |
| Hypertension |
2.9% |
| Pain |
2.5% |
| Product Used For Unknown Indication |
2.5% |
| Renal Failure Chronic |
2.5% |
| Breast Cancer |
1.7% |
| Paroxysmal Nocturnal Haemoglobinuria |
1.7% |
| Thrombocytosis |
1.7% |
| Anxiety |
1.2% |
| Atrial Fibrillation |
1.2% |
| Malaria Prophylaxis |
1.2% |
| Myelodysplastic Syndrome |
1.2% |
|
| Wound Infection Staphylococcal |
31.0% |
| Weight Decreased |
8.5% |
| Haemorrhage |
5.6% |
| Vomiting |
5.6% |
| Death |
4.2% |
| Haemoptysis |
4.2% |
| Stress Fracture |
4.2% |
| Acute Leukaemia |
2.8% |
| Aplasia Pure Red Cell |
2.8% |
| Drug Ineffective |
2.8% |
| Flatulence |
2.8% |
| Muscle Twitching |
2.8% |
| Myocardial Infarction |
2.8% |
| Oedema Peripheral |
2.8% |
| Rectal Haemorrhage |
2.8% |
| Red Blood Cell Count Decreased |
2.8% |
| Renal Artery Occlusion |
2.8% |
| Renal Artery Stenosis |
2.8% |
| Syncope |
2.8% |
| Tuberculosis |
2.8% |
|
| Interacting |
| Essential Thrombocythaemia |
60.0% |
| Drug Use For Unknown Indication |
20.0% |
| Thrombocytosis |
20.0% |
|
| Blood Creatinine Increased |
42.9% |
| Drug Interaction |
42.9% |
| Platelet Count Decreased |
14.3% |
|
